|
|
|
||||||||||||||
|
|
August 18, 2008 XStream Systems Introduces Its Technology to NCPD Membership
XStream Systems presented its unique authentication technology at the National Coalition of Pharmaceutical Distributors 3rd Annual Meeting in Las Vegas on August 12th. The NCPD meeting was held in conjunction with the Pharmacy Purchasing Outlook Meeting held at the Las Vegas Hilton.
Alan Clock, Senior Vice President of Sales and Marketing and John Lundquist, Vice President of Sales and Business Development, introduced XStream Systems’ revolutionary authentication technology which allows a pharmaceutical distributor to verify the contents of individual units of sale, inside its sealed container. XStream’s solution allows distributors to authenticate products in both the receiving and returns functions. This process of verification allows the individual or corporate entity to properly secure itself from adulterated, contaminated or counterfeit medications.
“This was a great opportunity to meet with a critical component of the domestic pharmaceutical supply chain” stated Clock. “NCPD members have largely been excluded from the regulatory debate which has left them disadvantaged by the current solutions of Track and Trace technologies. Our authentication technology exceeds the functionality of Track and Trace, but does not rely on a complex transactional process. This is a perfect solution for the average NCPD member.”
August 5, 2008 A National Defense Leader Elected to XStream Systems’ Board of Directors
XStream Systems, Inc., a material identification company specializing in pharmaceutical authentication announced that Philip A. Odeen, a leader in the National Defense Industry, has been elected to their Board of Directors.
Mr. Odeen served as President/CEO of BDM and Chairman/CEO of TRW, companies that were leaders in the defense market. Earlier, he served in senior positions under the Nixon administration for the Secretary of Defense and the National Security Council. He was Principal Deputy Assistant Secretary of Defense, and later worked directly under Henry Kissinger. In 1997, William Cohen, the U.S. Secretary of Defense, selected Odeen to chair the National Defense Panel. In 2003, Phil Odeen became a member of Northrop Grumman's board of directors. Phil has served as Chairman of several companies, including Reynolds & Reynolds, Convergys, Avaya, and AES.
“Mr. Odeen’s presence, expertise, and experience will be an invaluable asset to our Board as XStream Systems pushes forward to enhance public safety for our nation,” stated Brian Mayo, CEO and President.
July 9, 2008 XStream Systems to Present at Anti-Counterfeiting Conference
XStream Systems, Inc. announced today that it is scheduled to present at an Anti-Counterfeiting and Anti-Diversion conference which will be held on October 20 -21, 2008 in Vienna, Virginia.
The Center for Business Intelligence (CBI) has organized an annual conference to examine this extremely topical and important issue near the nation’s capitol.
The program of the conference is focused on preparing industry thought leaders for pending Federal Legislation and in the discussion of combating the illicit trade of pharmaceuticals by implementing security measures and tracking system. XStream will be presenting a break out titled; Materials Authentication and Verification within the Pharmaceutical Supply Chain: Working with and Moving Beyond Track and Trace.
“We are excited about discussing the alternative solutions that work with and go beyond the capabilities of Track and Trace technologies to a group of influential industry stakeholders, “stated Alan Clock, SVP of XStream Systems. “No one product or solution will totally protect the global and domestic drug supply, the attendees of this conference will have a major influence in shaping the protection of the medications on which we all rely.”
To find out more about the CBI Conference or XStream Systems, visit the sites below: http://cbinet.com/show_conference.cfm?confCode=PC08089
June 5, 2008 Material Identification Company Adds Strategist for Medication Safety
XStream Systems, Inc. announced the addition of Pat Earl, an Executive Business Strategist, as a consultant on business strategy for medication safety improvement in the pharmaceutical supply chain. XStream Systems, Inc.’s corporate office is located in Sebastian, Florida.
Pat has over twenty-two years of pharmaceutical distribution sales and operations experience and will be located in the Midwest. She brings in-depth knowledge of all facets of the pharmaceutical wholesale industry as well as institutional communications, Group Purchasing Organization relations and strategic development activities for hospitals and retail clients. During her tenure with two of the nation's largest pharmaceutical supply chain providers, she developed innovative and creative business strategies that enhanced sales revenues and increased market share.
“Pat has shown an exceptional blend of sales and operational success in developing and managing tactical and strategic relationships across the Pharmaceutical Industry, “stated Alan Clock, Senior Vice President of Sales and Marketing. “She has served in a number of industry capacities that focused on improving medication distribution and eliminating unsafe practices in the supply chain. Her contributions will be invaluable in our growth.”
April 9, 2008 Company Offers Unit which can Verify Drug Ingredients
A pharmaceutical authentication company is now selling equipment which can verify drug ingredients outside of a laboratory. XStream Systems, Inc. offers a unit which can read the molecular structure of medicines without having to open any packaging or break a bottle’s seal.
Named the XT250 System, its underlying technology was originally developed to protect the public from terrorist threats, but has since found its role in the pharmaceutical industry. It can tell if a drug is counterfeit, altered, contaminated, or otherwise different on a molecular level from its intended form.
“This unit is of great benefit when dealing with drugs or ingredients from questionable sources, such as what we’ve seen from China in the recent Heparin incident,” stated John Lundquist, VP of Business Development for XStream Systems. “The fact it can test drugs when they are still in the manufacturer’s packaging makes the system even more valuable to companies trying to keep their outbound shipments clean.”
The XT250 System is currently being used at multiple locations in the pharmaceutical supply network, checking inventories for dangerous products.
March 7, 2008 Editorial Series on Counterfeit Drug Liability Released
A four part opinion series of articles on supply chain liability within the pharmaceutical industry is now available to the public. The write-up covers how each segment of the US drug supply network questions where counterfeit drug liability lies.
Alan Clock, a 20 year veteran of the pharmaceutical industry, authored the series. “Nobody wants to be responsible for a passing on, ultimately to the consumer, counterfeit or fake medications,” Clock said. “The current reality is that every member of the pharmaceutical supply chain should be responsible and do everything possible to protect the public. Those members who haven’t adopted or embraced new technologies to authenticate or protect their inventories will appear as the weak link and be very vulnerable to those with a nefarious intent and liability.”
The final installment of the series covers a new piece of equipment which is being offered as a solution to mitigate risk within the pharmaceutical industry. The XT250 Authentication System from XStream Systems, Inc. verifies pharmaceuticals at a crystalline level and while in their original sealed packaging. The equipment can assist manufacturers, distributors, wholesalers, and dispensers when having to defend themselves over products which left their facilities.
The series can be viewed at http://securepharmachain.blogspot.com/2008/03/opinion-series-1-of-4-who-is-liable.html
February 22, 2008 Technology Company to Present Drug Verification Solution
XStream Systems, Inc. is scheduled to present their technology and pharmaceutical industry applications at a symposium in Orlando, Florida. The Seventh Pharmaceutical Powder X-Ray Diffraction Symposium (PPXRD-7) will take place February 25-28, 2008 at the Florida Hotel and Conference Center.
Contributing scientists from XStream Systems include Noureddine Anibou and Charles Dozier. The title of the oral presentation to be given is “EDXRD Probe for Pharmaceutical Verification.” While speaking, Dr. Anibou will discuss the importance of pharmaceutical verification and give an explanation of XStream Systems’ technology and its documented accuracy rates.
“I’m looking forward to present this unique application of EDXRD technology,” stated Dr. Anibou. “The XT250 Pharmaceutical Authentication System has proven itself time and again in accurately verifying solid state drugs.”
The PPXRD-7 event is one of many scheduled appearances by XStream Systems’ scientists at x-ray diffraction conferences across the nation.
To view a .pdf of the presentation, click here.
February 12,
2008 Pharmaceutical Authentication Company Names New CFO
XStream Systems, Inc.
announced the appointment of a new Chief Financial
Officer today. The high tech authentication company chose Chris Butler for
the executive position, effective February 1, 2008.
Ms. Butler has over 17 years of financial experience,
most recently as Vice President of Finance with multiple Fortune 250
companies. She has demonstrated a consistent track record of exceptional
strategic analysis, budgeting, forecasting, cash management, and risk
management.
In addition to her role as CFO, Ms. Butler will also
serve as Treasurer for XStream Systems.
“I
am very happy to report that Ms. Butler has accepted the positions,” stated
Brian Mayo, President of XStream Systems. “She will be instrumental in our
success as we offer our drug authentication solutions to the pharmaceutical
industry.”
Prior to beginning her career, Ms. Butler graduated Valedictorian of
University of Central Florida’s School of Business with a Bachelor’s degree
in Business Administration, concentrating in accounting. She later
graduated Summa Cum Laude with her Master’s degree in Taxation. Ms. Butler
passed the CPA exam in 1991 and was awarded the Elijah Watts Sells
Certificate of Distinction for her performance on the exam.
XStream Systems, Inc. announced the
completion of its annual ASA meeting. Authorized Sales Agents from multiple
territories joined the XStream Systems team at the Sebastian, Florida
headquarters for two nights and two days. The
major focus of the meeting was the pharmaceutical authentication solution
they are now all offering throughout the United States.
“Given the proliferation of counterfeit pharmaceuticals both here and
abroad, we are convinced that we have a unique solution. A technology which looks
inside sealed pharmaceutical containers will be a positive focus for
XStream and our ASA Partners.” stated Alan Clock, Senior Vice President of
Sales and Marketing for XStream Systems.
Senior executives and key representatives from Compass Engineering,
Omicron, Inc., Schlegel Associates, and Remetronix attended the meeting.
Also present was Eastern Applied Research
from
Lockport, New York.
After the gathering,
Bob Moll, General Manager of EAR stated “We
are excited to be involved with XStream and the caliber of people we have
met in the last few days.”
Topics covered included corporate
history and direction, sales techniques for the XT250TM System,
market focus, marketing tactics, and pharmaceutical industry practices.
Aside from the training, another key
event was the establishment of complete US Field Service Provider coverage.
This national support system enables any XT250 Material Identification
System to have a service provider ready at anytime, anywhere.
XStream Systems considered this year’s
ASA meeting a success. The corporation is looking forward to a great year
with their ASAs and FSPs, and is already looking ahead to 2009’s meeting.
XStream Systems, Inc.
XStream Systems produces next-generation equipment for
material identification. Their patented systems are based on
Energy-Dispersive X-Ray Diffraction (EDXRD) technology. The company’s XT250™
System enables testing of powders, pills AND entire sealed bottles. The
equipment’s superior sample penetration allows the identification of
contents inside opaque plastic, cardboard and even metal packaging. For more
information, call 1-800-597-1191 or visit
www.xstreamsystems.net.
Compass Engineering
Corporation
Compass Engineering has offices in Greensboro, Georgia and
Buffalo, New York. Their website can be found at
www.compassengr.com.
Eastern Applied Research
For over fifteen years, Eastern Applied Research has
been dedicated to providing cost-efficient and reliable service/support for
all models of coating measurement instruments.
They are accredited to ISO/IEC 17025 and can be found online at
www.easternapplied.com.
Omicron, Inc.
Omicron is considered a leader in the
United Kingdom for distribution of chromatography, spectroscopy,
tablet-testing equipment and systems for the pharmaceutical and associated
industries. Their corporate website is
www.omicron-uk.com.
Remetronix
Remetronix specializes in the seamless process delivery of
transportation, rigging, installation, calibration, de-installation and
relocation of medical imaging equipment and pharmaceutical devices on a
national level for Fortune 100 Original Equipment Manufacturers. On the web:
www.remetronix.com.
Schlegel Associates, Inc.
Schlegel Associates, Inc. is located in
Wilmington, Delaware
and can be
contacted at
(302) 477-1810.
A report titled Pharmaceutical Counterfeiting; a Global Healthcare
Menace: a New Technology Tool has been released. Written with six
different sub-categories, it is the newest information to date from
XStream Systems, Inc., an authentication solution company based in the
United States.
Noted subjects within the report include categories of counterfeits, the
outsourcing of pharmaceutical manufacturing and ingredient processing, and
the dramatic increase of fake medicine cases worldwide.
The white paper also addresses current measures to fight global
pharmaceutical counterfeiting and technological solutions aimed at
minimizing the public’s risks.
The author, Alan Clock stated “Americans trust the
pharmaceutical industry and our supply chain with their health. To retain
that trust, high-tech options must be taken into consideration when
developing ways to keep a growing problem from causing consumers to loose
faith in the authenticity of their medications.”
To view the new report in its entirety,
click here.
The
number of counterfeit medications in America and a possible solution to
protect consumers was broadcast across the nation today. FOX News Channel
aired a feature on XStream Systems and the unit which can authenticate
questionable medications.
The
story discussed the significant issues surrounding counterfeit medications
within the domestic supply chain and the use of technology, such as EDXRD
and the XT250 System as a solution. With this unit, manufacturers,
distributors, and dispensers can verify the contents of pharmaceutical
containers without breaking their seal. In addition the airing captured the
evolution of the XT250 System over the years.
The FOX
News Channel correspondent on the case was Orlando Salinas. Also featured
was Alan Clock, Senior Vice President of Sales and Marketing at XStream
Systems. “We were contacted by FOX about a possible visit to our
headquarters and our expertise regarding the scope of counterfeiting within
the US,” stated Clock. “Ultimately, the news footage proved to be a great
way to present our solution to a large audience.”
In his report, Salinas cited the WHO (World Health Organization) regarding
the increasing scope of counterfeit medications and ICE (Immigration Customs
Enforcement). This year, ICE has investigated over 200 cases of smuggling
of prescription medications and over 650 foreign internet sites that sell
into the United States.
As America’s
consumption of pharmaceuticals increases, so must methods to thwart the
counterfeit drug market. In 2006, prescription sales in the US
pharmaceutical market increased by 8.3% and in 2007, similar growth is
anticipated.
Global industry experts agree that on average 10% of
the world’s drug supply is considered counterfeit, adulterated or otherwise
fraudulent. With Americans purchasing 44% of all pharmaceuticals sold
worldwide last year, if only 1% of the US drug supply was tainted it would
equal 34.2 million prescriptions that are potentially life threatening. This
equates to approximately one counterfeit prescription for every nine
American citizens in 2006 alone.
The World Health Organization’s Anti-Counterfeiting
Taskforce has stated “technologies are particularly important for product
authentication.” To fill a need for a high-tech solution, scientists and
engineers at a Florida-based company have developed a unit which can help
maintain the integrity of the pharmaceutical supply chain. The XT250TM
System by XStream Systems, Inc. is the first of its kind and can verify the
contents of a manufacturer’s original unit of sale, without breaking the
seal or opening the package. When placed at distribution checkpoints or
warehouse facilities, the unit is able to determine fraudulent medications
from legitimate inventory, thus protecting the consumer.
A study by the Center for Medicine in the Public
Interest cited by the WHO estimates the number of counterfeits will climb to
be a $75 billion industry by the year 2010, representing a 92% increase from
2005. John Lundquist, XStream Systems’ VP of Business Development states “As
the threat of consumers being harmed by counterfeit drugs grows, we need to
increase the number of safeguards throughout the pharmaceutical supply
chain. The XT250 System is the most robust technology of a new generation of
necessary anti-counterfeiting solutions.”
XStream Systems, Inc.
announced
the addition of another key individual assisting the rollout of their
pharmaceutical authentication technology. John Lundquist has joined
the company
as Vice President of Sales and Business
Development.
Mr. Lundquist will report to Alan Clock, the
Senior Vice President of Sales and Marketing.
Mr.
Lundquist will be responsible for large enterprise sales and business
development efforts for XStream Systems.
“John’s experience is the perfect fit for
XStream Systems,” stated Clock. “We feel that he will be able to place our
product and its technology further into the healthcare supply chain.”
Mr. Lundquist joins XStream Systems with a strong
track record of experience in pharmaceutical sales, business development,
operations, supply chain and group purchasing management. Prior to joining
the XStream Systems team, Mr. Lundquist directed a national
Specialty/Biotech Distribution enterprise.
Mr. Lundquist is an
expert strategist and negotiator known for pioneering new business tactics
and partnerships aimed at pharmaceutical supply chain solutions. He has also
held executive positions with Managed Healthcare Associates,
AmerisourceBergen and Fujisawa USA.
Brian Mayo, President of XStream Systems, Inc., a Florida based
material identification company, announced the addition of
Alan Clock
as Senior Vice President of Sales and Marketing.
In
the position of Senior Vice President of Sales and Marketing, Mr. Clock will
be responsible for directing all sales and marketing efforts for XStream
Systems.
“Alan brings us a great amount of experience and expertise in the
pharmaceutical and healthcare provider markets,” stated Mayo. “We feel that
our product and its technology are the perfect fit for the healthcare supply
chain and the many issues that they have as they source products globally.
Alan gives us the contacts and credibility to properly provide our solution
to these markets and others.”
Mr. Clock joins XStream Systems with wealth of experience in sales and sales
management primarily dealing with healthcare services, systems and
solutions. He has held senior sales executive and national account roles for
industry leaders; AmerisourceBergen, McKesson, Cardinal Health and
ActiveHealth Management.
“I am excited about
this ground breaking technology and being at the forefront of providing
solutions to an uncertain global supply chain,” stated Clock. “XStream’s
first generation product, the XT250™ System is perfectly suited to help
authenticate materials at vulnerable spots along the supply chain
network.”
A
Florida-based company has begun selling a piece of equipment which can
detect counterfeit drugs in the U.S. pharmaceutical supply chain. XStream
Systems, Inc. developed a unit to identify dangerous pharmaceuticals
in circulation to protect the public by authenticating these
medications before they reach the consumer.
The threat of Americans swallowing counterfeit medications is increasing
each year. The World Health Organization has stated trade in fake medicines
is more prevalent in countries with weak drug regulation and enforcement,
scarcity or erratic supply of basic medicines, unregulated markets and
unaffordable prices. But as counterfeiting becomes more sophisticated, these
products are increasingly present even in better controlled markets. Daniel
M. Durand, VP of Sales for XStream Systems says “Some undeveloped nations
see regions where circulated counterfeit pharmaceutical rates soar into the
high 30th percentile – to protect the public, we need to take
action and make sure medications are validated before consumption.”
XStream Systems’ unit authenticates a drug while still in its sealed
container. The “fingerprint” of each drug is completely unique, so
questionable medications can be compared to the actual drug’s fingerprint.
To do this, an operator places a bottle into the unit and presses the
“start” button on a touch screen. The molecular crystal structure of the
drug is then examined and compared against stored data to receive a “passed”
or “failed” message.
To
date, U.S. Immigration and Customs Enforcement has initiated over 178
criminal investigations of pharmaceutical smuggling. These investigations
have targeted over 650 websites and millions of dosage units of counterfeit,
adulterated, misbranded and unapproved pharmaceuticals – all available to
American consumers.
XStream Systems’ unit is the first of its kind.
XStream Systems, Inc.
XStream Systems
produces next-generation equipment for material identification. Their
patented systems are based on Energy-Dispersive X-Ray Diffraction (EDXRD)
technology. The company’s XT250™ System enables testing of powders, pills
AND entire sealed bottles. The equipment’s superior sample penetration
allows the identification of contents inside opaque plastic, cardboard and
even metal packaging.
June 14th, 2007 Phase II of Independent Laboratory Evaluations
The XStream Systems XT250 Material
Identification System has completed phase II of independent testing. Once
again, the results have proven the accuracy of the unit. This particular
round of testing was completed using some prescription medications prone to
counterfeiting:
XT250 (Field
Test Plan) Independent Lab Test Plan – Phase II Executive Summary.
This report is being submitted to
satisfy a contractual agreement and contains the results of an independent
evaluation of a technology developed by XStream Systems, Inc. (Vero Beach,
FL). The evaluation was performed by the Florida Technical Division of
Midwest Research Institute (Palm Bay, FL). The purpose of this independent
evaluation was to test the sensitivity and specificity of the XStream
Systems, Inc. XT250 Material Recognition System Engine in identifying known
prescription drugs based on simple pass/fail criteria. Combiviv 150/300,
Epivir 150, Viagra 100, Truvada 200/300, and Hyzaar 50/12.5 were provided by
XStream Systems, Inc and pills were dispensed into sample vials. An MRI
scientist performed all testing at the XStream Systems, Inc. facility. The
instrument was programmed to identify all 5 of the test samples and testing
was conducted over a six day period. The evaluation consisted of 50
independent runs performed on each of the five samples used in this analysis
with the instrument programmed for positive identification and 50
independent runs on each of the five samples with the instrument programmed
for misidentification for a total of 500 measurements. Equal volumes (18.5
cm3) of each
sample were exposed for 5 minutes. The results showed that the XT250
accurately identified 97.2% of the positive samples (N=250). The instrument
accurately identified 249 out of 250 negative samples, demonstrating a
specificity of 99.6%. The overall efficiency (accuracy) of the diagnostic
test, defined as the percentage of samples correctly classified, was 98.4%;
492 out of the 500 samples. The calculated probability of the XT250
correctly classifying these drugs was 0.986. Statistical analysis by a Chi
Squared Test demonstrated there was no statistically significant difference
between the observed results and the expected results, X2YATES
(1, N=500) = 0.100, p=0.752. These test results indicate that
the XStream Systems Inc. XT250 Material Recognition System Engine accurately
classified 492 out of 500 drug samples in this evaluation.
Vero Beach, FL— Businesses
across the nation have begun reading about a company offering a high-tech
solution to a growing concern: counterfeit medicine. A national business to
business ad campaign has begun introducing the pharmaceutical manufacturing
and distribution industries to XStream Systems, Inc. and their
next-generation technology. Using X-ray based detection equipment, the company’s XT250 System can
verify medications by looking at their molecular structure. “Each medication
has a unique molecular fingerprint that we can scan and identify a drug as
being real or counterfeit” says Daniel M. Durand, VP of XStream Systems.
“Counterfeit pharmaceuticals are a real threat to the industry and the
public. We are reaching out across the nation to let the pharmaceutical
industry know they have another option in the fight against these
counterfeits with an easy-to-use system that can detect phony medications
with greater than 99% accuracy. ” XStream Systems is headquartered in Vero Beach, FL and in the midst of
tremendous growth. Brian Mayo, CEO of the company described the activity
within the facility at a “fever pitch”. Postcards and direct mail pieces
are being sent out over the course of four weeks, seeding key players in the
industry with news of much needed technology coming their way.
Advertisements for the XStream Systems’ XT250 Material Identification System
are appearing in this month’s “Healthcare Distributor” magazine. Even the
XStream Systems’ national trade show circuit is going into high gear, with
the company appearing at eight shows in the first half of 2007 alone. “There is no doubt the pharmaceutical industry is an enormous target
market” says Michael DeBoer of XStream Systems, “so we are being very
selective on who and how we hit first.” DeBoer adds, “Our
equipment can be used in many different industries, but this one seems to
fit real well. The pharmaceutical community is trying to figure out how to
fight counterfeits as we are letting them know we are here to help- we have
begun connecting”.
Headquartered in Vero Beach, XStream Systems produces next-generation
equipment for material identification. Their patented systems are based on
energy-dispersive X-ray diffraction (EDXRD), a highly sensitive and accurate
technology previously available only in expensive, high-end systems used by
major laboratories. They bring on-site, real-time material identification
within the reach of nearly any organization. Greater Than 99% Accuracy Rate The XStream Systems XT250 has
recently completed independent testing. The results from the process prove a 99.4% accuracy rate when
identifying pharmaceuticals. This is a phenomenal achievement for a material
identification system, and XStream Systems is proud to post the
following summary: XT250 Independent
Laboratory Evaluation Executive Summary. This report is being submitted to satisfy a
contractual agreement and contains the results of an independent evaluation of a technology developed
by XStream Systems, Inc. (Vero Beach, FL). The evaluation was performed by the
Florida Technical Division of the Midwest Research Institute (MRI, was to test the sensitivity and specificity of the
XStream Systems, Inc. XT250 Material Recognition System Engine in identifying known over
the counter (OTC) pharmaceuticals using a simple pass/fail
criteria. Tagamet HB 200, Aleve, Dramamine, Motrin IB, Nuprin, Zantac 150, and BC Powder were
purchased by MRI staff. Expiration dates and lot numbers were recorded and
pills were dispensed into sample vials. Sample materials were kept in the
possession of MRI for the duration of the evaluation. An MRI scientist performed all
testing at the XStream Systems, Inc. facility following a 10 minute training session provided by
XStream Systems, Inc. technical staff. The instrument was programmed to identify three of the
eight test samples, and testing was conducted over a three day period. The
evaluation consisted of 20 independent runs performed on each of the eight samples used in this
analysis; totaling 160 measurements. Equal volumes (18.5 cm3) of each sample were exposed for 10 minutes. The
results showed that the XT250 accurately identified 98% of the
samples (n=60). Only one compound was misidentified in one out of 20
replicates, Dramamine, and was independent of lot number or expiration date.
The instrument accurately identified all negative samples (n= 100), demonstrating a specificity
of 100%. The overall efficiency (accuracy) of the diagnostic test, defined as the
percentage of samples correctly classified, was 99.38%; 159 out of the 160
samples. The calculated probability of the XT250 correctly classifying these drugs was
0.98. Statistical analysis by a Chi Squared Test demonstrated no statistically significant
difference between the observed results and the expected results, X2Yates = (1,
N=160) = 0.0067, p=0.94 These test results indicate that the XStream Systems Inc. XT250 Material
Recognition System Engine accurately classified 159 out of 160 drug samples in this initial
evaluation. Kimball Electronics Group, Inc., (www.kegroup.com)
through its related subsidiaries, announced today that the company has
entered into an agreement with XStream Systems, Inc. to manufacture their
XT250 Material Identification System. Kimball Electronics Group, Inc., a
subsidiary of Kimball International, Inc. (NASDAQ:KBALB), is a global
contract electronics manufacturing services (EMS) company that specializes in
durable electronics with applications in the public safety, automotive,
medical, and industrial controls industries. XStream Systems, Inc. is a
company that ds and sesignells next-generation material identification
equipment for verification and detection of substances as wide-ranging as
illicit drugs, pharmaceuticals, chemicals, and food products. Don Charron, President, Kimball Electronics Group, stated, "We are
excited about being the strategic manufacturing partner for XStream, and we
believe that their newly developed and patented Energy-Dispersive X-Ray Diffraction
(EDXRD) technology will quickly establish them as a market leader." Brian Mayo, President and CEO, XStream Systems, said, "Kimball's
commitment to be both a business partner as well as a supplier is very
important to XStream and we look forward to a long lasting
relationship." Jim Thyen, President and CEO of Kimball International, Inc., said,
"XStream Systems, Inc. has developed a unique, innovative product
providing a valuable service for the public safety in our communities. We are
honored to be chosen as the preferred supplier and to have earned the
opportunity this brings for growth and diversification." Under the terms of the agreement, Kimball Electronics will assemble, test,
service, and repair the XT250 x-ray system in their Jasper, About Kimball Electronics: Kimball Electronics Group is well recognized for its excellent quality,
reliability and innovative service. The September 2005 issue of
"Electronic Business" magazine ranked Kimball Electronics as
#26among the global Top 100 Contract Manufacturers. In June
2005,"Electronics Supply & Manufacturing" magazine rated
Kimball Electronics #20 among the Top 50 Electronics Manufacturing Services
Companies. Kimball Electronics Group has manufacturing operations in the To learn more about Kimball Electronics, visit the Company's
website on the Internet at: www.kegroup.com About XStream Systems, Inc.: XStream Systems, Inc., founded in 2004, is headquartered in About Kimball International: Recognized with a reputation for excellence, Kimball International is
committed to a high performance culture that values personal and
organizational commitment to quality, reliability, value, speed, and ethical
behavior. Kimball employees know they are part of a corporate culture that
builds success for customers while enabling employees to share in the
company's success through personal, professional and financial growth. Kimball International, Inc. (NASDAQ:KBALB) provides a variety of products
from its two business segments: the Furniture and Cabinets segment and the
Electronic Contract Assemblies segment. The Electronic Contract Assemblies segment
provides engineering and manufacturing services which utilize common
production and support capabilities to a variety of industries globally. The
Furniture and Cabinets segment provides furniture for the office and
hospitality industries, sold under the Company's family of brand names. The
Furniture and Cabinets segment also provides engineering and manufacturing
services which utilize common production and support capabilities on a
contract basis to customers primarily in the residential furniture and
cabinets industry. To learn more about Kimball International, Inc., visit the Company's
website on the Internet at:
http://www.kimball.com/ "Kimball International ... We Build Success!" |